Peregrine Ventures

Israel's first dedicated healthcare fund, investing in life science companies globally.

Venture Capital Active Or Yehuda, Israel Est. 2001
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
3
in our dataset
Rounds participated
5
Rounds led
0
Rounds' value
$3.3M
total disclosed, rounds participated
Stages
Pre-Seed, E Round, Seed, C Round, A Round, B Round, D Round

About

Peregrine Ventures is a leading Israeli venture capital fund established in 2001, dedicated to advancing medical innovation through strategic investments in life sciences. The firm invests across all stages of a company's lifecycle, from pre-seed through advanced growth stages, with a focus on healthcare, life sciences, digital health, medical devices, pharmaceuticals, and biotechnology. Peregrine Ventures provides comprehensive support beyond capital, including business strategy, team recruitment, and regulatory navigation. The firm manages over $300 million in assets and has a global investment strategy, with a particular interest in opportunities within Asia.

Portfolio · 3

Althea Medical
Minimally Invasive Catheter-based Solution
3 rounds $1.4M committed Latest: 2024-01
CureSign
Monitoring Cancer Treatment Efficacy
1 round Latest: 2020-02
Neovasc
Medical Device Company
1 round $1.9M committed Latest: 2008-06

Investment activity

17 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences47
Agriculture & Food Technologies4
Business Software4
Industrial Technologies1
Fintech & Insurtech1
Cyber Security1
Undisclosed1

Funds · 6

  • Peregrine III Annex Fund — $30M Jan 2021
  • Peregrine Growth Fund — $180.18M Jun 2020
  • Peregrine Fund IV — $115M Dec 2019
  • Peregrine Fund III — $75M Apr 2015
  • Peregrine Fund II — $27M Sep 2008
  • Peregrine Fund I — $15M Apr 2001

Q&A

What is Peregrine Ventures' primary investment focus?
Peregrine Ventures is an Israeli healthcare fund, primarily focusing on the Health Tech & Life Sciences sector, which accounts for 47 of its portfolio companies.
What was a recent notable exit for Peregrine Ventures?
In January 2026, Peregrine Ventures saw BioProtect acquired by Almeda Ventures for $200 million.
Can you name another recent exit for Peregrine Ventures?
In January 2025, Peregrine Ventures had an exit with EndoStream Medical, which was acquired by Kaneka Corporation for $100 million.
Which funds has Peregrine Ventures raised recently?
Peregrine Ventures raised the Peregrine III Annex Fund for $30 million in January 2021 and the Peregrine Growth Fund for $180.18 million in June 2020.
What is Peregrine Ventures' investment stage preference?
Peregrine Ventures invests across various stages including Pre-Seed, Seed, A Round, B Round, C Round, D Round, and E Round.
Who are the co-founders of Peregrine Ventures?
The co-founders and Managing General Partners of Peregrine Ventures are Boaz Lifschitz and Eyal Lifschitz.
What is Peregrine Ventures' most significant portfolio company by funding raised?
Insightec, a company developing MR-guided Focused Ultrasound Systems, has raised $592.9 million, making it one of Peregrine Ventures' most significantly funded portfolio companies.
How many investment rounds has Peregrine Ventures participated in within the last year?
In 2025, Peregrine Ventures participated in 19 investment rounds, and in 2024, they participated in 12 investment rounds.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)